Merck & Co Inc
NYSE:MRK

Watchlist Manager
Merck & Co Inc Logo
Merck & Co Inc
NYSE:MRK
Watchlist
Price: 95.2 USD 1.98%
Market Cap: 240.8B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+24%
Revenue
Forecast
+5%
Operating Income
Forecast
+12%
Net Income
Forecast
+17%

Wall Street
Price Targets

MRK Price Targets Summary
Merck & Co Inc

Wall Street analysts forecast MRK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRK is 118.13 USD with a low forecast of 95.95 USD and a high forecast of 155.4 USD.

MRK Lowest Forecast
Wall Street Target
95.95 USD
1% Upside
MRK Average Forecast
Wall Street Target
118.13 USD
24% Upside
MRK Highest Forecast
Wall Street Target
155.4 USD
63% Upside
Lowest
Price Target
95.95 USD
1% Upside
Average
Price Target
118.13 USD
24% Upside
Highest
Price Target
155.4 USD
63% Upside
Merck & Co Inc Competitors:
Price Targets
ANCR
Animalcare Group PLC
48% Upside
PSG
PharmaSGP Holding SE
61% Upside
SNT
Syntara Ltd
53% Upside
INVA
Innoviva Inc
12% Upside
ANCR
Animalcare Group PLC
48% Upside
PSG
PharmaSGP Holding SE
61% Upside
SNT
Syntara Ltd
53% Upside
INVA
Innoviva Inc
12% Upside
T
300119
Tianjin Ringpu Bio-Technology Co Ltd
24% Upside
PAHC
Phibro Animal Health Corp
9% Upside
FULC
Fulcrum Therapeutics Inc
91% Upside
C
000661
Changchun High & New Technology Industries Group Inc
70% Upside

Revenue
Forecast

Revenue Estimate
Merck & Co Inc

For the last 8 years the compound annual growth rate for Merck & Co Inc's revenue is 6%. The projected CAGR for the next 3 years is 5%.

6%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Merck & Co Inc

For the last 8 years the compound annual growth rate for Merck & Co Inc's operating income is 11%. The projected CAGR for the next 3 years is 12%.

11%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-19%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Merck & Co Inc

For the last 8 years the compound annual growth rate for Merck & Co Inc's net income is 20%. The projected CAGR for the next 3 years is 17%.

20%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-44%
Average Miss
What are analyst estimates?

See Also

Summary
MRK intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRK stock valuation using valuation multiples.
Wall Street Estimates
MRK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRK's stock price target?
Price Target
118.13 USD

According to Wall Street analysts, the average 1-year price target for MRK is 118.13 USD with a low forecast of 95.95 USD and a high forecast of 155.4 USD.

What is Merck & Co Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Merck & Co Inc's revenue is 6%. The projected CAGR for the next 3 years is 5%.

What is Merck & Co Inc's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Merck & Co Inc's operating income is 11%. The projected CAGR for the next 3 years is 12%.

What is Merck & Co Inc's Net Income forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Merck & Co Inc's net income is 20%. The projected CAGR for the next 3 years is 17%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 237,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.